These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25301482)

  • 1. Incidence and predictors of persistent growth hormone deficiency (GHD) in patients with isolated, childhood-onset GHD.
    Smyczyńska J; Stawerska R; Lewiński A; Hilczer M
    Endokrynol Pol; 2014; 65(5):334-41. PubMed ID: 25301482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
    Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
    Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect on adult height of pubertal growth hormone retesting and withdrawal of therapy in patients with previously diagnosed growth hormone deficiency.
    Zucchini S; Pirazzoli P; Baronio F; Gennari M; Bal MO; Balsamo A; Gualandi S; Cicognani A
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4271-6. PubMed ID: 16912138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of growth hormone therapy on Taiwanese children with growth hormone deficiency.
    Huang YH; Wai YY; Van YH; Lo FS
    J Formos Med Assoc; 2012 Jul; 111(7):355-63. PubMed ID: 22817812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth hormone (GH) secretion in patients with childhood-onset GH deficiency: retesting after one year of therapy and at final height.
    Thomas M; Massa G; Maes M; Beckers D; Craen M; François I; Heinrichs C; Bourguignon JP;
    Horm Res; 2003; 59(1):7-15. PubMed ID: 12566729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transient Isolated, Idiopathic Growth Hormone Deficiency-A Self-Limiting Pediatric Disease with Male Predominance or a Diagnosis Based on Uncertain Criteria? Lesson from 20 Years' Real-World Experience with Retesting at One Center.
    Smyczyńska J; Hilczer M; Smyczyńska U; Lewiński A; Stawerska R
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of idiopathic childhood-onset growth hormone deficiency (GHD) on bone mass in subjects without adult GHD.
    Lange M; Müller J; Svendsen OL; Kastrup KW; Juul A; Feldt-Rasmussen U
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):18-23. PubMed ID: 15638865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic parameters and adipokine profile during GH replacement therapy in children with GH deficiency.
    Ciresi A; Amato MC; Criscimanna A; Mattina A; Vetro C; Galluzzo A; D'Acquisto G; Giordano C
    Eur J Endocrinol; 2007 Mar; 156(3):353-60. PubMed ID: 17322495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy.
    Gleeson HK; Gattamaneni HR; Smethurst L; Brennan BM; Shalet SM
    J Clin Endocrinol Metab; 2004 Feb; 89(2):662-6. PubMed ID: 14764778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Response to growth hormone treatment in isolated growth hormone deficiency versus multiple pituitary hormone deficiency.
    Darendeliler F; Lindberg A; Wilton P
    Horm Res Paediatr; 2011; 76 Suppl 1():42-6. PubMed ID: 21778748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone (GH) deficiency (GHD) of childhood onset: reassessment of GH status and evaluation of the predictive criteria for permanent GHD in young adults.
    Maghnie M; Strigazzi C; Tinelli C; Autelli M; Cisternino M; Loche S; Severi F
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1324-8. PubMed ID: 10199773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness, economical and safety aspects of growth hormone (GH) therapy in growth promoting doses in patients with isolated GH deficiency after the attainment of near-final height. Is there a need to modify the criteria of therapy withdrawal?
    Smyczyńska J; Hilczer M; Lewinski A; Smyczyńska U; Stawerska R
    Pediatr Endocrinol Diabetes Metab; 2021; 27(4):258-265. PubMed ID: 35114767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
    Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
    J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
    Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessment of the optimal growth hormone cut-off level in insulin tolerance testing for growth hormone secretion in patients with childhood-onset growth hormone deficiency during transition to adulthood.
    Bonfig W; Bechtold S; Bachmann S; Putzker S; Fuchs O; Pagel P; Schwarz HP
    J Pediatr Endocrinol Metab; 2008 Nov; 21(11):1049-56. PubMed ID: 19189699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do all patients with childhood-onset growth hormone deficiency (GHD) and ectopic neurohypophysis have persistent GHD in adulthood?
    Léger J; Danner S; Simon D; Garel C; Czernichow P
    J Clin Endocrinol Metab; 2005 Feb; 90(2):650-6. PubMed ID: 15546901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of permanent growth hormone deficiency (GHD) in young adults with childhood onset GHD: a multicenter study.
    Berberoğlu M; Sıklar Z; Darendeliler F; Poyrazoğlu S; Darcan S; Işgüven P; Bideci A; Ocal G; Bundak R; Yüksel B; Arslanoğlu I
    J Clin Res Pediatr Endocrinol; 2008; 1(1):30-7. PubMed ID: 21318062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3.
    Juul A; Kastrup KW; Pedersen SA; Skakkebaek NE
    J Clin Endocrinol Metab; 1997 Apr; 82(4):1195-201. PubMed ID: 9100596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency.
    Juul A; Bernasconi S; Clayton PE; Kiess W; DeMuinck-Keizer Schrama S;
    Horm Res; 2002; 58(5):233-41. PubMed ID: 12401943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is retesting in growth hormone deficient children really useful?
    Meazza C; Gertosio C; Pagani S; Pilotta A; Tinelli C; Buzi F; Farello G; Genoni G; Bona G; Bozzola M
    Minerva Endocrinol; 2017 Dec; 42(4):325-330. PubMed ID: 27304071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.